Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability

Stroke; a journal of cerebral circulation

Volumn 46, Issue 8, 2015, Pages 2341-2346

  Campbell, Bruce C V ^a   Meretoja, Atte ^a   Donnan, Geoffrey A ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cerebral infarction; computerized tomography; Institute of Neurological Disorders and Stroke; National; numbers need to treat; stroke; tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; DISABLED PERSON; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STROKE; TIME; TRENDS;

ADMINISTRATION, INTRAVENOUS; CEREBRAL HEMORRHAGE; DISABLED PERSONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84944710325     PISSN: None     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007564     Document Type: Review

References (0)